Skip to main content

Advertisement

SpringerLink
Log in

Update on depression in neurologic illness: Stroke, epilepsy, and multiple sclerosis

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

The risk of depression is increased in chronic neurologic illness and can adversely affect the course of disease. Recent literature is reviewed for depression in stroke, epilepsy, and multiple sclerosis. Depression can share pathophysiologic aspects of the comorbid illness, such as neurotransmitter pathway disturbances, hypothalamuspituitary-adrenal pathway disturbances, and changes in immunologic function. Depression also can be a psychologic reaction to the burden of the neurologic condition. Risk factors for development of depression are reviewed. Depression and other medical conditions can have shared symptoms (eg, fatigue, psychomotor retardation) that can complicate the diagnosis of depression in neurologic illness. Proper selection of antidepressant treatment is necessary to avoid worsening the neurologic disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rickards H: Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 2005, 76(Suppl 1):i48–52.

    PubMed  Google Scholar 

  2. Robinson RG: Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003, 54:326–387.

    Google Scholar 

  3. Williams LS, Ghose SS, Swindle RW: Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 2004, 161:1090–1095.

    PubMed  Google Scholar 

  4. Tank WK, Chan SS, Chiu HF, et al.: Poststroke depression in Chinese patients: frequency, psychosocial, clinical, and radiological determinants. J Geriatr Psychiatry Neurol 2005, 18:45–51.

    Google Scholar 

  5. Vataja R, Leppavuori A, Pohjasvaara T, et al.: Poststroke depression and lesion location revisited. J Neuropsychiatr Clin Neursci 2004, 16:156–162.

    CAS  Google Scholar 

  6. Robinson RG: Post-stroke mood disorder. Hosp Pract 1986, 83–89.

  7. Cassidy E, O’Connor R, O’Keane V: Prevalence of post-stroke depression in an Irish sample and its relationship with disability and outcome following inpatient rehabilitation. Disabil Rehab 2004, 26:71–77.

    Google Scholar 

  8. Carson AJ, McHale S, Allen K, et al.: Depression after a stroke and lesion locator synthesis: a systematic review. Lancet 2000, 356:122–126.

    PubMed  CAS  Google Scholar 

  9. Narushima K, Kosier JT, Robinson RG: A reappraisal of poststroke depression, intra- and inter hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 2003, 5:423–430.

    Google Scholar 

  10. Desmond DW, Remien RH, Moroney JT, et al.: Ischemic stroke and depression. J Internat Meurophysiol Soc 2003, 9:429–439.

    Google Scholar 

  11. Rapoport MJ, McCullagh S, Shammi P, et al.: Cognitive impairment associated with major depression following mild and moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci 2005, 17:61–65.

    PubMed  Google Scholar 

  12. Tang WK, Ungvari GS, Chiu HF, et al.: Detecting depression in Chinese stroke patients: a pilot study comparing four screening instruments. Int J Psychiatry Med 2004, 34:155–163.

    PubMed  Google Scholar 

  13. Tang WK, Ungvari GS, Chiu HF, et al.: Screening post-stroke depression in Chinese older adults using the hospital anxiety and depression scale. Aging Mental Health 2004, 8:397–399.

    PubMed  CAS  Google Scholar 

  14. Dieguez S, Staub F, Bruggimann L, et al.: Is poststroke depression a vascular depression? (Review). J Neurol Sci 2004, 226:53–58. This article examines how stroke and depression can each predispose patients to the other condition. It is an excellent review of the concept of poststroke depression as being vascular in origin.

    PubMed  Google Scholar 

  15. Kim JM, Stewart R, Shin IS, et al.: Vascular disease/risk and late-life depression in a Korean community population. Br J Psychiatry 2004, 185:102–107.

    PubMed  Google Scholar 

  16. Neu P, Schlattmann P, Schilling A, et al.: Cerebrovascular reactivity in major depression: a pilot study. Psychosom Med 2004, 66:6–8.

    PubMed  Google Scholar 

  17. Mast BT, MacNeill SE, Lichtenberg PA: Post-stroke and clinically-defined vascular depression in geriatric rehabilitation patients. Am J Geriatr Psychiatry 2004, 12:84–92.

    PubMed  Google Scholar 

  18. Lipsey JY, Robinson RG, Pearlson GD, et al.: Nortriptyline treatment of post stroke depression: a double-blind study. Lancet 1984, 1:297–300.

    PubMed  CAS  Google Scholar 

  19. Hackett ML, Anderson CS, House AO: Interventions for treating depression after stroke. [Review]. Cochrane Database Syst Rev 2004, 3:CD003437.

    PubMed  Google Scholar 

  20. Rampello L, Chiechio S, Nicoletti G, et al.: Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology 2004, 173:73–78.

    PubMed  CAS  Google Scholar 

  21. Andersen G, Vestergaard K, Lauritzen L: Effective treatment of post stroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994, 25:1099–1104.

    PubMed  CAS  Google Scholar 

  22. Niedermaier N, Bohrer E, Schulte K, et al.: Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry 2004, 65:1619–1623.

    Article  PubMed  CAS  Google Scholar 

  23. Fruehald S, Gatterbauer E, Rehak P, et al.: Early fluoxetine treatment of post-stroke depression- a three-month doubleblind placebo-controlled study with an open-abel long-term follow-up. J Neurol 2003, 250:347–351.

    Google Scholar 

  24. Jorge RE, Robinson RG, Arndt S, et al.: Mortality and poststroke depression, a placebo-controlled trial of antidepressants. Am J Psychiatry 2003, 160:1823–1829.

    PubMed  Google Scholar 

  25. Erikkson M, Asplund K, Glader EL, et al.: Self-reported depression and use of antidepressants after stroke: a national survey. Stroke 2004, 35:936–941.

    Google Scholar 

  26. Wiart L, Petit H, Joseph PA, et al.: Fluoxetine in early poststroke depression: the double-blind placebo-controlled study. Stroke 2000, 31:1829–1832.

    PubMed  CAS  Google Scholar 

  27. Paolucci S, Antonucci G, Grasso MG, et al.: Poststroke oppression, antidepressant treatment and rehabilitation results. A case-controlled study. Cerebrovasc Dis 2001, 12:264–271.

    PubMed  CAS  Google Scholar 

  28. Kimura M, Robinson RG, Kosier JT: Treatment of cognitive impairment after post of depression: a double-blind treatment trial. Stroke 2001, 32:1048–1049.

    Google Scholar 

  29. Cole MG, Elie LM, McCusker J: Feasibility and effectiveness of treatments for post-stroke depression and elderly inpatients: systematic review. J Geriatr Psychiatry Neurol 2001, 14:37–41.

    PubMed  CAS  Google Scholar 

  30. Jorge RE, Robinson RG, Tateno A, et al.: Repetitive transcranial magnetic stimulation is treatment of poststroke depression: a preliminary study. Biol Psychiatry 2004, 55:398–405.

    PubMed  Google Scholar 

  31. Lincoln NB, Flannaghan T: Cognitive behavioral psychotherapy for depression following strokes: a randomized controlled trial. Stroke 2003, 34:111–115.

    PubMed  CAS  Google Scholar 

  32. Shoemaker N: Depression and stroke. Improving patient outcomes with a team approach. Caring 2001, 20:6–8.

    PubMed  CAS  Google Scholar 

  33. Davis MC: Life review therapy as an intervention to manage depression and enhance life satisfaction in individuals with right hemisphere cerebral vascular accidents. Issues Mental Health Nurs 2004, 5:503–515.

    Google Scholar 

  34. Jones JE, Hermann BP, Barry H, et al.: Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci 2005, 17:172–179.

    PubMed  Google Scholar 

  35. Ettinger A, Reed M, Cramer J: Epilepsy Impact Project Group. Depression and comorbidity in community based patients with epilepsy or asthma Neurology 2004, 636:1008–1014.

    Google Scholar 

  36. Beghi E, Spagnoli P, Airoldi L, et al.: Emotional and affective disturbances in patients with epilepsy. Epilepsy Behav 2002, 3:225–261.

    Google Scholar 

  37. Schmitz B: Depression and mania in patients with epilepsy. Epilepsia 2005, 46(Suppl 4):45–49.

    Article  PubMed  Google Scholar 

  38. Piazzini A, Canevini MP, Maggiori G, Canger R: Depression and anxiety in patients with epilepsy. Epilepsy Behav 2001, 2:481–489.

    PubMed  Google Scholar 

  39. Victoroff JI, Benson F, Grafton ST, et al.: Depression in complex partial seizures. Electroencephalograhy and cerebral metabolic correlates. Arch Neurol 1994, 51:155–163.

    PubMed  CAS  Google Scholar 

  40. Quiske A, Helmstaedter C, Lux S, Elger CE: Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000, 39:121–125. Beck Depression Inventory was administered to 60 patients. Multivariate analysis indicated significantly higher score in mesial temporal sclerosis regardless of lesion lateralization.

    PubMed  CAS  Google Scholar 

  41. Helmstaedter C, Sonntag-Dillender M, Hoppe C, Elger CE: Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus of lateralization and localization. Epilepsy Behav 2004, 5:696–701.

    PubMed  Google Scholar 

  42. Mazza M, Orsucci F, De Riso S, et al.: Epilepsy and depression: risk factor for suicide? Clin Ter 2004, 155:425–427.

    PubMed  CAS  Google Scholar 

  43. Caplan R, Siddarth P, Gurbani S, et al.: Depression and anxiety in pediatric epilepsy. Epilepsia 2005, 46:720–730.

    PubMed  Google Scholar 

  44. Forsgren L, Nystrom L: An incident case referent study of epileptic seizures in adults. Epilepsy Res 1990, 6:66–81.

    PubMed  CAS  Google Scholar 

  45. Herdorffer DC, Hauser WA, Annegers JF, Cascino G: Major depression is a risk factor for seizures in older adults. Ann Neurol 2000, 47:246–249.

    Google Scholar 

  46. Kanner AM, Balabanov A: Depression and epilepsy: how closely related are they? Neurology 2002, 58(8 Supp 5):27–39.

    Google Scholar 

  47. Jobe P: Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 2003, 4(Supp 3):14–24.

    Google Scholar 

  48. Kanner AM: Depression in epilepsy: a frequently neglected multifaceted disorder. Epilepsy Behav 2003, 4(Suppl_4):11–19.

    PubMed  Google Scholar 

  49. Paradiso S, Hermann BP, Blumer D, et al.: Impact of depressed mood on neuropsychological status in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2001, 70:180–185.

    PubMed  CAS  Google Scholar 

  50. Altshuler L, Rausch R, Delrahim S, et al.: Temporal lobe epilepsy, temporal lobectomy and major depression. J Neuropsychiatry Clin Neurosci 1999, 11:436–443.

    PubMed  CAS  Google Scholar 

  51. Reuber M, Andersen B, Elger CE, Helmstaedter C: Depression and Anxiety before and after temporal lobe epilepsy. Seizure 2004, 13:129–135.

    PubMed  Google Scholar 

  52. Cankurtaran ES, Ulug B, Saygi S, et al.: Psychiatric morbidity, quality of life and disability in mesial temporal lobe epilepsy patients before and after surgery. Epilepsy Behav 2005, 7:116–122. Abstract.

    PubMed  CAS  Google Scholar 

  53. Wrench J, Wilson SJ, Bladin PF: Mood disturbance before and after seizure surgery: a comparison of temporal and extra temporal lobe resection. Epilepsia 2004, 45:534–543.

    PubMed  Google Scholar 

  54. Quigg M, Broshek DK, Heidel-Schiltz S, et al.: Depression in intractable partial epilepsy varies by laterality of focus and surgery. Epilepsia 2003, 44:419–424.

    PubMed  Google Scholar 

  55. Glosser G, Zwil AS, Glosser DS, et al.: Psychiatric aspects of TLE before and after anterior temporal lobectomy. Neurol Neurosurg Psychiatry 2000, 68:53–55.

    CAS  Google Scholar 

  56. Derry PA, Rose KJ, McLaclan RS: Moderators of the effect of preoperative emotional adjustment on post operative depression after surgery for temporal lobe epilepsy. Epilepsia 2000, 41:177–188.

    PubMed  CAS  Google Scholar 

  57. Selai C, Bannister D, Trimble M: Antiepileptic drugs and the regulation of mood and quality of life (QOL): The evidence from epilepsy. Epilepsia 2005, 46(Supp 4):50.

    Article  PubMed  CAS  Google Scholar 

  58. Kalinin VV, Polyanskiy DA: Gender differences in risk factor of suicidal behavior in epilepsy. Epilepsy Behav 2005, 6:424–429.

    PubMed  Google Scholar 

  59. Aldenkamp A-P, Arends J, Bootsma H-P, et al.: Randomized double blind parallel group study comparing cognitive effects of a low dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 2002, 43:19–26.

    PubMed  CAS  Google Scholar 

  60. Lopez-Gomez M, Ramirez-Bermudez J, Campillo C, et al.: Primidone is associated with interictal depression in patients with epilepsy. Epilepsy Behav 2005, 6:413–416.

    PubMed  CAS  Google Scholar 

  61. Savic I, Lindstrom P, Gulyas B, et al.: Limbic reduction of 5HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004, 52:1343–1351.

    Google Scholar 

  62. Theodore WH: Does serotonin play a role in epilepsy? Epilepsy Curr 2003, 3:173–177. This review discusses experimental research preformed on 5HT receptors. The article explores the role of 5HT in the shared pathogenesis of depression and epilepsy.

    PubMed  Google Scholar 

  63. Pericic D, Lazic J, Svob Strac D: Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. Brain Res 2005, 1033:90–95.

    PubMed  CAS  Google Scholar 

  64. Clinkers R, Smolders I, Meurs A, et al.: Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J Neurochem 2004, 89:834–843.

    Google Scholar 

  65. Hernandez EJ, Williams PA, Dudek FE: Effects of fluoxetine and TFMPP on spontenous seizures in Rats with pilocarpine induced epilepsy. Epilepsia 2002, 43:1337–1345.

    PubMed  CAS  Google Scholar 

  66. Specchio LM, Iudice A, Specchio N, et al.: Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 2004, 27:133–136.

    PubMed  CAS  Google Scholar 

  67. Preuter C, Norra C: Mood disorders and their treatment in patients with epilepsy. J Neuropsychiatry Clin Neurosci 2005, 17:20–28.

    Google Scholar 

  68. Willer CJ, Ebers GC: Susceptibility to multiple sclerosis: interplay between genes and environment. Curr Opin Neurol 2000, 13:241–247.

    PubMed  CAS  Google Scholar 

  69. Sotgiu S, Pugliatti M, Fois ML, et al.: Genes, environment, and susceptibility to multiple sclerosis. Neurobiol Dis 2004, 17:131–143.

    PubMed  CAS  Google Scholar 

  70. Minden SL, Orav J, Reich P: Depression in multiple sclerosis. Gen Hosp Psychiatry 1987, 9:426–434.

    PubMed  CAS  Google Scholar 

  71. Sandovnick AD, Remick RA, Allen J, et al.: Depression and multiple sclerosis. Neurology 1996, 46:629–632.

    Google Scholar 

  72. Joffe RT, Lippert GP, Gray TA, et al.: Mood disorder and multiple sclerosis. Arch Neurol 1987, 44:376–378.

    PubMed  CAS  Google Scholar 

  73. Schiffer RB, Caine ED, Bamford KA, Levy S: Depressive episodes in patients with multiple sclerosis. AM J Psychiatry 1983, 140:1498–1500.

    PubMed  CAS  Google Scholar 

  74. Paten SB, Beck CA, Williams JV, et al.: Depression in multiple sclerosis: a population based perspective. Neurology 2003, 61:1524–1527.

    Google Scholar 

  75. Sadovnik AD, Eisen RN, Ebers GC, Paty DW: Cause of death in patients attending multiple sclerosis clinics. Neurology 1991, 41:1193–1196.

    Google Scholar 

  76. Feinstein A, Roy P, Lobaugh N, Feinstein K, et al.: Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004, 62:586–590.

    PubMed  CAS  Google Scholar 

  77. Pujol J, Bello J, Deus J, Cardoner N, et al.: A. Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region. Psychiatry Res 2000, 99:151–159.

    PubMed  CAS  Google Scholar 

  78. Berg D, Supprian T, Thomaae J, et al.: Lesion Pattern in patients with multiple sclerosis and dperssion. Mult Scler 2000, 6:156–162.

    PubMed  CAS  Google Scholar 

  79. Benesova Y, Neidermayerova I, Mechl M, Havlikova P: The relation between brain MRI lesions and depressive symptoms in multiple sclerosis. Bratisl Lek Listy 2003, 104:174–176.

    PubMed  CAS  Google Scholar 

  80. Zorzon M, De Masi R, Nasuelli D, et al.: Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 2001, 248:416–421.

    PubMed  CAS  Google Scholar 

  81. Zorzon M, Zivadinoov R, Nasuelli D, et al.: Depressive symptoms and MRI changes in multiple sclerosis. Eur J Neurol 2002, 9:491–496.

    PubMed  CAS  Google Scholar 

  82. Baskshi R, Zxzrnecki D, Shaikh ZA, Priore RL, et al.: Brain MRI lesions and atrophy are related to depression in multiple sclerosis 2003, 9:284–288.

    Google Scholar 

  83. Zhbad RK, Patten SB, Metz L: The association of depression with disease course in multiple sclerosis. Neurology 2005, 64:359–360.

    Google Scholar 

  84. Mikova O, Yakimova R, Bosmans E, et al.: Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001, 11:203–208.

    PubMed  CAS  Google Scholar 

  85. Kahl KG, Kruse N, Faller H, et al.: Expression of tumor necrosis factor alpha and interferon gamma mRNA in blood cell correlates with depression cores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology 2002, 27:671–681.

    PubMed  CAS  Google Scholar 

  86. Mohr DC, Gookin DE, Idlar J, et al.: Treatment of depression is associated with nonspecific and antigen specific T(H)1 responses in multiple sclerosis. Arch Neurol 2001, 58:1081–1086.

    PubMed  CAS  Google Scholar 

  87. Randolph JJ, Arnet PA: Depression and fatigue in relapsingremitting MS: the role of symptomatic variability. Mult Scler 2005, 11:186–190.

    PubMed  Google Scholar 

  88. Jannsens AC, van Doorn PA, de Boer JB, et al.: Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression and disease related distress. J Clin Epidemiol 2004, 57:180–186.

    Google Scholar 

  89. Jopson NM, Moss-Morris R: The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res 2003, 54:503–311.

    PubMed  Google Scholar 

  90. Kneebone II, Dunmore EC, Evans E: Symptoms of depression in older adults with multiple sclerosis (MS): comparison with a matched sample of younger adults. Aging Ment Health 2003, 7:182–185.

    PubMed  CAS  Google Scholar 

  91. Feinstein A: Multiple sclerosis, disease modifying treatments and depression: a critical methodological review. Mult Scler 2000, 6:343–348.

    PubMed  CAS  Google Scholar 

  92. Klapper MD: Letter to the editor [letter]. Neurology 1994, 44:188.

    PubMed  CAS  Google Scholar 

  93. Jacobs LD, Beck RW, Simon JH, et al.: Intramuscular interferon Beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. New Engl J Med 2000, 343:898–904.

    PubMed  CAS  Google Scholar 

  94. Patten SB, Metz LM: Interferon B1a and depression in secondary progressive MS: Data from the SPECTRIMS trial. Neurology 2002, 59:744–746.

    PubMed  CAS  Google Scholar 

  95. Patten SB, Metz LM: Interferon beta-1a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial. Multiple Scler 2001, 7:243–248.

    CAS  Google Scholar 

  96. Feinstein A, O’Connor P, Feinstein K: Multiple sclerosis, interferon beta 1-b and depression: A prospective investigation. J Neurol 2002, 249:815–820.

    PubMed  Google Scholar 

  97. Mohr DC, Likosky W, Dwyer P, et al.: Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis. Arch Neurol 1999, 56:1263–1265.

    PubMed  CAS  Google Scholar 

  98. Patten SB, Fridhandler S, Beck CA, Metz LM: Epressive symptoms in a treated multiple sclerosis cohort. Mult Scler 2003, 9:616–619.

    PubMed  Google Scholar 

  99. Patten SB, Francis G, Metz LM, Lopez-Bresnahan M, Chang P, Curtin F, et al.: The relationship between depression and interferon beta therapy in patients with multiple sclerosis. Mult Scler 2005, 11:175–181.

    PubMed  CAS  Google Scholar 

  100. Benedetti F, Campori E, Colombo C, Smeraldi E: Fluvoxamine treatment of major depression associated with multiple sclerosis. J Neuropsychiatry Clin Neurosci 2004, 16:364–366.

    PubMed  CAS  Google Scholar 

  101. Schiffer RB, Wineman NM: Antidpressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990, 147:1493–1497.

    PubMed  CAS  Google Scholar 

  102. Brank Y, Ur E, Achiron A: Mclobemide treatment in multiple sclerosis patients with comorbid depression: an open label safety trial. J Neuropsychiatry Clin Neurosci 1999, 11:271–273.

    Google Scholar 

  103. Scott TF, Nussbaum P, McConnell H, Brill P: Measurement of treatment response to sertraline in multiple sclerosis patients using the Carroll Scale. Neurol Res 1995, 7:421–422.

    Google Scholar 

  104. Feinstein A: The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2004, 49:157–163.

    PubMed  Google Scholar 

  105. Mohr DC, Boudewy AC, Goodkin DE, et al.: Comparative outcomes for individual cognitive behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of deprssion in multiple sclerosis. J Consulting Clin Psychol 2001, 69:942–949.

    CAS  Google Scholar 

  106. Mohr DC, Gookin DE: Treatment of Depression in multiple sclerosis. Clin Psychol Sci Pract 1999, 6:1–9.

    Google Scholar 

  107. Tesar N, Baumhackl U, Kopp M, Gunther V: Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurologica Scandinavica 2003, 107:394–399.

    PubMed  CAS  Google Scholar 

  108. Mohr DC, Likosky W, Bertagnolli A, et al.: Telephone administered cognitive behavioral therapy for treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 2000, 68:356–361.

    PubMed  CAS  Google Scholar 

  109. Rodgers D, Khoo K, MacEachen M, et al.: Cognitive therapy for multiple sclerosis: a preliminary study. Altern Ther Health Med 1996, 2:70–74.

    PubMed  CAS  Google Scholar 

  110. Mohr DC, Hart SL, Goldberg A: Effects of treatment for depression on fatigue in multiple sclerosis. Pscyhosom Med 2003, 65:542–547.

    Google Scholar 

  111. Messmer UM, Mancuso ML, Battaglia MA, et al.: Peer support groups in multiple sclerosis: curret effectiveness and future directions. Mult Scler 2004, 10:80–84.

    Google Scholar 

  112. Mohr DC, Burke H, Beckner V, Merluzzi N: A preliminary report on a skills-based telephone-administered peer support program for patients with multiple sclerosis. Mult Scler 2005, 11:222–226.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Jefferson Medical College, 1518 Walnut Street, Suite 1110, 19102, Philadelphia, PA, USA

    Richard M. Sobel MD, FAPA

Authors
  1. Richard M. Sobel MD, FAPA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan Lotkowski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Mandel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sobel, R.M., Lotkowski, S. & Mandel, S. Update on depression in neurologic illness: Stroke, epilepsy, and multiple sclerosis. Curr Psychiatry Rep 7, 396–403 (2005). https://doi.org/10.1007/s11920-005-0043-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-005-0043-2

Keywords

Search

Navigation